nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—hematologic cancer—muscle cancer	0.572	1	CtDrD
Betamethasone—PTGS2—muscle cancer	0.255	1	CbGaD
Betamethasone—PTGS2—Etoposide—muscle cancer	0.0312	0.306	CbGbCtD
Betamethasone—ABCB1—Dactinomycin—muscle cancer	0.0183	0.179	CbGbCtD
Betamethasone—ABCB1—Vincristine—muscle cancer	0.0112	0.11	CbGbCtD
Betamethasone—ABCB1—Etoposide—muscle cancer	0.0103	0.101	CbGbCtD
Betamethasone—ABCB1—Doxorubicin—muscle cancer	0.00703	0.0689	CbGbCtD
Betamethasone—ABCB1—Methotrexate—muscle cancer	0.00681	0.0668	CbGbCtD
Betamethasone—CYP3A4—Vincristine—muscle cancer	0.00674	0.0661	CbGbCtD
Betamethasone—CYP3A4—Etoposide—muscle cancer	0.00617	0.0605	CbGbCtD
Betamethasone—CYP3A4—Doxorubicin—muscle cancer	0.00421	0.0413	CbGbCtD
Betamethasone—PTGS2—hindlimb—muscle cancer	0.000996	0.0786	CbGeAlD
Betamethasone—PLA2G1B—renal system—muscle cancer	0.000934	0.0737	CbGeAlD
Betamethasone—PTGS2—appendage—muscle cancer	0.000854	0.0674	CbGeAlD
Betamethasone—PLA2G1B—head—muscle cancer	0.000625	0.0493	CbGeAlD
Betamethasone—PLA2G1B—testis—muscle cancer	0.000604	0.0476	CbGeAlD
Betamethasone—NR3C2—smooth muscle tissue—muscle cancer	0.00048	0.0379	CbGeAlD
Betamethasone—NR3C2—renal system—muscle cancer	0.000462	0.0365	CbGeAlD
Betamethasone—PGR—smooth muscle tissue—muscle cancer	0.000447	0.0353	CbGeAlD
Betamethasone—NR3C2—cardiac atrium—muscle cancer	0.000414	0.0327	CbGeAlD
Betamethasone—NR3C2—tendon—muscle cancer	0.000361	0.0285	CbGeAlD
Betamethasone—NR3C2—vagina—muscle cancer	0.000335	0.0264	CbGeAlD
Betamethasone—NR3C1—embryo—muscle cancer	0.000328	0.0259	CbGeAlD
Betamethasone—PGR—vagina—muscle cancer	0.000311	0.0246	CbGeAlD
Betamethasone—NR3C2—head—muscle cancer	0.000309	0.0244	CbGeAlD
Betamethasone—NR3C2—testis—muscle cancer	0.000299	0.0236	CbGeAlD
Betamethasone—PGR—head—muscle cancer	0.000288	0.0227	CbGeAlD
Betamethasone—PTGS2—embryo—muscle cancer	0.000284	0.0224	CbGeAlD
Betamethasone—PGR—testis—muscle cancer	0.000278	0.0219	CbGeAlD
Betamethasone—CYP19A1—head—muscle cancer	0.000259	0.0204	CbGeAlD
Betamethasone—NR3C1—smooth muscle tissue—muscle cancer	0.000258	0.0203	CbGeAlD
Betamethasone—CYP19A1—testis—muscle cancer	0.00025	0.0197	CbGeAlD
Betamethasone—NR3C1—renal system—muscle cancer	0.000248	0.0196	CbGeAlD
Betamethasone—PTGS2—smooth muscle tissue—muscle cancer	0.000223	0.0176	CbGeAlD
Betamethasone—NR3C1—cardiac atrium—muscle cancer	0.000222	0.0175	CbGeAlD
Betamethasone—PTGS2—renal system—muscle cancer	0.000215	0.0169	CbGeAlD
Betamethasone—Acute coronary syndrome—Vincristine—muscle cancer	0.0002	0.00339	CcSEcCtD
Betamethasone—Rash erythematous—Doxorubicin—muscle cancer	0.000199	0.00337	CcSEcCtD
Betamethasone—Myocardial infarction—Vincristine—muscle cancer	0.000199	0.00337	CcSEcCtD
Betamethasone—Neuropathy peripheral—Vincristine—muscle cancer	0.000199	0.00337	CcSEcCtD
Betamethasone—Fungal infection—Doxorubicin—muscle cancer	0.000197	0.00334	CcSEcCtD
Betamethasone—Necrosis—Doxorubicin—muscle cancer	0.000194	0.00329	CcSEcCtD
Betamethasone—NR3C1—tendon—muscle cancer	0.000194	0.0153	CbGeAlD
Betamethasone—Abscess—Doxorubicin—muscle cancer	0.000192	0.00326	CcSEcCtD
Betamethasone—Herpes simplex—Methotrexate—muscle cancer	0.000191	0.00323	CcSEcCtD
Betamethasone—Stinging—Doxorubicin—muscle cancer	0.000188	0.00318	CcSEcCtD
Betamethasone—Glycosuria—Doxorubicin—muscle cancer	0.000188	0.00318	CcSEcCtD
Betamethasone—CYP3A4—renal system—muscle cancer	0.000188	0.0148	CbGeAlD
Betamethasone—NR3C1—bone marrow—muscle cancer	0.000188	0.0148	CbGeAlD
Betamethasone—Ulcer—Methotrexate—muscle cancer	0.000186	0.00315	CcSEcCtD
Betamethasone—Petechiae—Doxorubicin—muscle cancer	0.000185	0.00314	CcSEcCtD
Betamethasone—Hallucination—Vincristine—muscle cancer	0.000181	0.00307	CcSEcCtD
Betamethasone—Vasculitis—Methotrexate—muscle cancer	0.00018	0.00305	CcSEcCtD
Betamethasone—Alopecia—Dactinomycin—muscle cancer	0.00018	0.00305	CcSEcCtD
Betamethasone—NR3C1—vagina—muscle cancer	0.00018	0.0142	CbGeAlD
Betamethasone—Sweating increased—Etoposide—muscle cancer	0.000179	0.00304	CcSEcCtD
Betamethasone—Erythema—Dactinomycin—muscle cancer	0.000177	0.003	CcSEcCtD
Betamethasone—ABCB1—embryo—muscle cancer	0.000175	0.0139	CbGeAlD
Betamethasone—Extravasation—Doxorubicin—muscle cancer	0.000175	0.00296	CcSEcCtD
Betamethasone—Amenorrhoea—Doxorubicin—muscle cancer	0.000173	0.00294	CcSEcCtD
Betamethasone—Skin exfoliation—Methotrexate—muscle cancer	0.000168	0.00284	CcSEcCtD
Betamethasone—PTGS2—tendon—muscle cancer	0.000168	0.0132	CbGeAlD
Betamethasone—Arthropathy—Doxorubicin—muscle cancer	0.000167	0.00284	CcSEcCtD
Betamethasone—NR3C1—head—muscle cancer	0.000166	0.0131	CbGeAlD
Betamethasone—Herpes simplex—Doxorubicin—muscle cancer	0.000165	0.0028	CcSEcCtD
Betamethasone—Angiopathy—Vincristine—muscle cancer	0.000165	0.0028	CcSEcCtD
Betamethasone—Ill-defined disorder—Dactinomycin—muscle cancer	0.000165	0.00279	CcSEcCtD
Betamethasone—PTGS2—bone marrow—muscle cancer	0.000162	0.0128	CbGeAlD
Betamethasone—Acute coronary syndrome—Etoposide—muscle cancer	0.000162	0.00274	CcSEcCtD
Betamethasone—Ulcer—Doxorubicin—muscle cancer	0.000161	0.00273	CcSEcCtD
Betamethasone—Neuropathy peripheral—Etoposide—muscle cancer	0.000161	0.00273	CcSEcCtD
Betamethasone—Myocardial infarction—Etoposide—muscle cancer	0.000161	0.00273	CcSEcCtD
Betamethasone—Alopecia—Vincristine—muscle cancer	0.000161	0.00272	CcSEcCtD
Betamethasone—NR3C1—testis—muscle cancer	0.00016	0.0127	CbGeAlD
Betamethasone—Malaise—Dactinomycin—muscle cancer	0.00016	0.00271	CcSEcCtD
Betamethasone—Ecchymosis—Methotrexate—muscle cancer	0.000159	0.00269	CcSEcCtD
Betamethasone—Pulmonary oedema—Methotrexate—muscle cancer	0.000157	0.00265	CcSEcCtD
Betamethasone—PTGS2—vagina—muscle cancer	0.000156	0.0123	CbGeAlD
Betamethasone—Hiccups—Doxorubicin—muscle cancer	0.000152	0.00258	CcSEcCtD
Betamethasone—Myalgia—Dactinomycin—muscle cancer	0.000151	0.00256	CcSEcCtD
Betamethasone—Dermatitis contact—Doxorubicin—muscle cancer	0.000151	0.00255	CcSEcCtD
Betamethasone—Discomfort—Dactinomycin—muscle cancer	0.000149	0.00253	CcSEcCtD
Betamethasone—Thrombophlebitis—Methotrexate—muscle cancer	0.000147	0.0025	CcSEcCtD
Betamethasone—Diabetes mellitus—Methotrexate—muscle cancer	0.000147	0.00249	CcSEcCtD
Betamethasone—Skin exfoliation—Doxorubicin—muscle cancer	0.000145	0.00246	CcSEcCtD
Betamethasone—Oedema—Dactinomycin—muscle cancer	0.000145	0.00245	CcSEcCtD
Betamethasone—Fluid retention—Doxorubicin—muscle cancer	0.000145	0.00245	CcSEcCtD
Betamethasone—Infection—Dactinomycin—muscle cancer	0.000144	0.00244	CcSEcCtD
Betamethasone—PTGS2—head—muscle cancer	0.000144	0.0113	CbGeAlD
Betamethasone—Neuropathy—Doxorubicin—muscle cancer	0.000143	0.00242	CcSEcCtD
Betamethasone—Vertigo—Vincristine—muscle cancer	0.000142	0.00241	CcSEcCtD
Betamethasone—Thrombocytopenia—Dactinomycin—muscle cancer	0.000142	0.0024	CcSEcCtD
Betamethasone—Dry eye—Doxorubicin—muscle cancer	0.000141	0.00238	CcSEcCtD
Betamethasone—Oesophagitis—Doxorubicin—muscle cancer	0.000139	0.00236	CcSEcCtD
Betamethasone—Anorexia—Dactinomycin—muscle cancer	0.000138	0.00234	CcSEcCtD
Betamethasone—Eye disorder—Etoposide—muscle cancer	0.000138	0.00233	CcSEcCtD
Betamethasone—Ecchymosis—Doxorubicin—muscle cancer	0.000138	0.00233	CcSEcCtD
Betamethasone—Convulsion—Vincristine—muscle cancer	0.000137	0.00233	CcSEcCtD
Betamethasone—Hypertension—Vincristine—muscle cancer	0.000137	0.00232	CcSEcCtD
Betamethasone—Pulmonary oedema—Doxorubicin—muscle cancer	0.000136	0.0023	CcSEcCtD
Betamethasone—Myalgia—Vincristine—muscle cancer	0.000135	0.00229	CcSEcCtD
Betamethasone—Visual disturbance—Methotrexate—muscle cancer	0.000135	0.00228	CcSEcCtD
Betamethasone—Angiopathy—Etoposide—muscle cancer	0.000134	0.00227	CcSEcCtD
Betamethasone—ABCB1—renal system—muscle cancer	0.000133	0.0105	CbGeAlD
Betamethasone—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000132	0.00223	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000132	0.00223	CcSEcCtD
Betamethasone—Alopecia—Etoposide—muscle cancer	0.00013	0.00221	CcSEcCtD
Betamethasone—Lethargy—Methotrexate—muscle cancer	0.00013	0.00221	CcSEcCtD
Betamethasone—Anaphylactic shock—Vincristine—muscle cancer	0.000129	0.00219	CcSEcCtD
Betamethasone—Oedema—Vincristine—muscle cancer	0.000129	0.00219	CcSEcCtD
Betamethasone—Infection—Vincristine—muscle cancer	0.000128	0.00218	CcSEcCtD
Betamethasone—Thrombophlebitis—Doxorubicin—muscle cancer	0.000128	0.00216	CcSEcCtD
Betamethasone—Osteoarthritis—Methotrexate—muscle cancer	0.000128	0.00216	CcSEcCtD
Betamethasone—Diabetes mellitus—Doxorubicin—muscle cancer	0.000127	0.00215	CcSEcCtD
Betamethasone—Nervous system disorder—Vincristine—muscle cancer	0.000127	0.00215	CcSEcCtD
Betamethasone—Thrombocytopenia—Vincristine—muscle cancer	0.000127	0.00215	CcSEcCtD
Betamethasone—Decreased appetite—Dactinomycin—muscle cancer	0.000126	0.00213	CcSEcCtD
Betamethasone—Hyperhidrosis—Vincristine—muscle cancer	0.000125	0.00212	CcSEcCtD
Betamethasone—Fatigue—Dactinomycin—muscle cancer	0.000125	0.00211	CcSEcCtD
Betamethasone—Pain—Dactinomycin—muscle cancer	0.000124	0.0021	CcSEcCtD
Betamethasone—Anorexia—Vincristine—muscle cancer	0.000123	0.00209	CcSEcCtD
Betamethasone—Eye pain—Doxorubicin—muscle cancer	0.000122	0.00207	CcSEcCtD
Betamethasone—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000122	0.00207	CcSEcCtD
Betamethasone—Irritability—Methotrexate—muscle cancer	0.000122	0.00206	CcSEcCtD
Betamethasone—Mood swings—Methotrexate—muscle cancer	0.000121	0.00205	CcSEcCtD
Betamethasone—Hypotension—Vincristine—muscle cancer	0.000121	0.00205	CcSEcCtD
Betamethasone—Feeling abnormal—Dactinomycin—muscle cancer	0.000119	0.00202	CcSEcCtD
Betamethasone—Ill-defined disorder—Etoposide—muscle cancer	0.000119	0.00202	CcSEcCtD
Betamethasone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000118	0.00201	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000118	0.002	CcSEcCtD
Betamethasone—Increased appetite—Doxorubicin—muscle cancer	0.000118	0.00199	CcSEcCtD
Betamethasone—Insomnia—Vincristine—muscle cancer	0.000117	0.00198	CcSEcCtD
Betamethasone—Paraesthesia—Vincristine—muscle cancer	0.000116	0.00197	CcSEcCtD
Betamethasone—Malaise—Etoposide—muscle cancer	0.000116	0.00196	CcSEcCtD
Betamethasone—Dermatitis bullous—Doxorubicin—muscle cancer	0.000116	0.00196	CcSEcCtD
Betamethasone—Vertigo—Etoposide—muscle cancer	0.000115	0.00195	CcSEcCtD
Betamethasone—Body temperature increased—Dactinomycin—muscle cancer	0.000114	0.00194	CcSEcCtD
Betamethasone—Abdominal pain—Dactinomycin—muscle cancer	0.000114	0.00194	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000114	0.00193	CcSEcCtD
Betamethasone—Cardiac failure—Doxorubicin—muscle cancer	0.000113	0.00192	CcSEcCtD
Betamethasone—Loss of consciousness—Etoposide—muscle cancer	0.000113	0.00191	CcSEcCtD
Betamethasone—Lethargy—Doxorubicin—muscle cancer	0.000113	0.00191	CcSEcCtD
Betamethasone—Decreased appetite—Vincristine—muscle cancer	0.000112	0.0019	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Vincristine—muscle cancer	0.000112	0.00189	CcSEcCtD
Betamethasone—Fatigue—Vincristine—muscle cancer	0.000112	0.00189	CcSEcCtD
Betamethasone—Convulsion—Etoposide—muscle cancer	0.000111	0.00188	CcSEcCtD
Betamethasone—Hypertension—Etoposide—muscle cancer	0.000111	0.00188	CcSEcCtD
Betamethasone—Pain—Vincristine—muscle cancer	0.000111	0.00187	CcSEcCtD
Betamethasone—Osteoarthritis—Doxorubicin—muscle cancer	0.000111	0.00187	CcSEcCtD
Betamethasone—Migraine—Doxorubicin—muscle cancer	0.000109	0.00184	CcSEcCtD
Betamethasone—Affect lability—Doxorubicin—muscle cancer	0.000109	0.00184	CcSEcCtD
Betamethasone—Discomfort—Etoposide—muscle cancer	0.000108	0.00183	CcSEcCtD
Betamethasone—Gastrointestinal pain—Vincristine—muscle cancer	0.000106	0.00179	CcSEcCtD
Betamethasone—Cardiac arrest—Doxorubicin—muscle cancer	0.000105	0.00178	CcSEcCtD
Betamethasone—Anaphylactic shock—Etoposide—muscle cancer	0.000105	0.00177	CcSEcCtD
Betamethasone—Mood swings—Doxorubicin—muscle cancer	0.000105	0.00177	CcSEcCtD
Betamethasone—Infection—Etoposide—muscle cancer	0.000104	0.00176	CcSEcCtD
Betamethasone—Asthenia—Dactinomycin—muscle cancer	0.000104	0.00176	CcSEcCtD
Betamethasone—Thrombocytopenia—Etoposide—muscle cancer	0.000103	0.00174	CcSEcCtD
Betamethasone—Tachycardia—Etoposide—muscle cancer	0.000102	0.00173	CcSEcCtD
Betamethasone—Body temperature increased—Vincristine—muscle cancer	0.000102	0.00173	CcSEcCtD
Betamethasone—Abdominal pain—Vincristine—muscle cancer	0.000102	0.00173	CcSEcCtD
Betamethasone—Dry skin—Doxorubicin—muscle cancer	0.000101	0.00172	CcSEcCtD
Betamethasone—Hyperhidrosis—Etoposide—muscle cancer	0.000101	0.00172	CcSEcCtD
Betamethasone—Hypokalaemia—Doxorubicin—muscle cancer	0.000101	0.0017	CcSEcCtD
Betamethasone—ABCB1—bone marrow—muscle cancer	0.0001	0.00793	CbGeAlD
Betamethasone—Anorexia—Etoposide—muscle cancer	9.99e-05	0.00169	CcSEcCtD
Betamethasone—Diarrhoea—Dactinomycin—muscle cancer	9.9e-05	0.00168	CcSEcCtD
Betamethasone—Hypotension—Etoposide—muscle cancer	9.79e-05	0.00166	CcSEcCtD
Betamethasone—Muscular weakness—Doxorubicin—muscle cancer	9.75e-05	0.00165	CcSEcCtD
Betamethasone—ABCB1—vagina—muscle cancer	9.62e-05	0.00759	CbGeAlD
Betamethasone—Conjunctivitis—Methotrexate—muscle cancer	9.56e-05	0.00162	CcSEcCtD
Betamethasone—Paraesthesia—Etoposide—muscle cancer	9.41e-05	0.00159	CcSEcCtD
Betamethasone—Asthenia—Vincristine—muscle cancer	9.28e-05	0.00157	CcSEcCtD
Betamethasone—Vomiting—Dactinomycin—muscle cancer	9.2e-05	0.00156	CcSEcCtD
Betamethasone—Rash—Dactinomycin—muscle cancer	9.13e-05	0.00155	CcSEcCtD
Betamethasone—Decreased appetite—Etoposide—muscle cancer	9.11e-05	0.00154	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Etoposide—muscle cancer	9.04e-05	0.00153	CcSEcCtD
Betamethasone—Fatigue—Etoposide—muscle cancer	9.03e-05	0.00153	CcSEcCtD
Betamethasone—Pain—Etoposide—muscle cancer	8.96e-05	0.00152	CcSEcCtD
Betamethasone—ABCB1—head—muscle cancer	8.89e-05	0.00701	CbGeAlD
Betamethasone—Haemoglobin—Methotrexate—muscle cancer	8.88e-05	0.0015	CcSEcCtD
Betamethasone—Diarrhoea—Vincristine—muscle cancer	8.85e-05	0.0015	CcSEcCtD
Betamethasone—Haemorrhage—Methotrexate—muscle cancer	8.83e-05	0.0015	CcSEcCtD
Betamethasone—Weight increased—Doxorubicin—muscle cancer	8.7e-05	0.00147	CcSEcCtD
Betamethasone—Weight decreased—Doxorubicin—muscle cancer	8.64e-05	0.00146	CcSEcCtD
Betamethasone—Feeling abnormal—Etoposide—muscle cancer	8.63e-05	0.00146	CcSEcCtD
Betamethasone—Hyperglycaemia—Doxorubicin—muscle cancer	8.62e-05	0.00146	CcSEcCtD
Betamethasone—Nausea—Dactinomycin—muscle cancer	8.6e-05	0.00146	CcSEcCtD
Betamethasone—ABCB1—testis—muscle cancer	8.58e-05	0.00678	CbGeAlD
Betamethasone—Gastrointestinal pain—Etoposide—muscle cancer	8.57e-05	0.00145	CcSEcCtD
Betamethasone—Dizziness—Vincristine—muscle cancer	8.55e-05	0.00145	CcSEcCtD
Betamethasone—Visual impairment—Methotrexate—muscle cancer	8.51e-05	0.00144	CcSEcCtD
Betamethasone—Neuropathy peripheral—Doxorubicin—muscle cancer	8.35e-05	0.00141	CcSEcCtD
Betamethasone—Urticaria—Etoposide—muscle cancer	8.32e-05	0.00141	CcSEcCtD
Betamethasone—Body temperature increased—Etoposide—muscle cancer	8.28e-05	0.0014	CcSEcCtD
Betamethasone—Abdominal pain—Etoposide—muscle cancer	8.28e-05	0.0014	CcSEcCtD
Betamethasone—Conjunctivitis—Doxorubicin—muscle cancer	8.28e-05	0.0014	CcSEcCtD
Betamethasone—Eye disorder—Methotrexate—muscle cancer	8.25e-05	0.0014	CcSEcCtD
Betamethasone—Vomiting—Vincristine—muscle cancer	8.22e-05	0.00139	CcSEcCtD
Betamethasone—Rash—Vincristine—muscle cancer	8.15e-05	0.00138	CcSEcCtD
Betamethasone—Dermatitis—Vincristine—muscle cancer	8.15e-05	0.00138	CcSEcCtD
Betamethasone—Headache—Vincristine—muscle cancer	8.1e-05	0.00137	CcSEcCtD
Betamethasone—Angiopathy—Methotrexate—muscle cancer	8.01e-05	0.00136	CcSEcCtD
Betamethasone—Alopecia—Methotrexate—muscle cancer	7.81e-05	0.00132	CcSEcCtD
Betamethasone—Bradycardia—Doxorubicin—muscle cancer	7.79e-05	0.00132	CcSEcCtD
Betamethasone—Erythema—Methotrexate—muscle cancer	7.69e-05	0.0013	CcSEcCtD
Betamethasone—Haemoglobin—Doxorubicin—muscle cancer	7.69e-05	0.0013	CcSEcCtD
Betamethasone—Nausea—Vincristine—muscle cancer	7.68e-05	0.0013	CcSEcCtD
Betamethasone—Haemorrhage—Doxorubicin—muscle cancer	7.65e-05	0.0013	CcSEcCtD
Betamethasone—Asthenia—Etoposide—muscle cancer	7.52e-05	0.00127	CcSEcCtD
Betamethasone—Pruritus—Etoposide—muscle cancer	7.41e-05	0.00126	CcSEcCtD
Betamethasone—Visual impairment—Doxorubicin—muscle cancer	7.37e-05	0.00125	CcSEcCtD
Betamethasone—Diarrhoea—Etoposide—muscle cancer	7.17e-05	0.00121	CcSEcCtD
Betamethasone—Eye disorder—Doxorubicin—muscle cancer	7.15e-05	0.00121	CcSEcCtD
Betamethasone—Ill-defined disorder—Methotrexate—muscle cancer	7.13e-05	0.00121	CcSEcCtD
Betamethasone—Angiopathy—Doxorubicin—muscle cancer	6.94e-05	0.00118	CcSEcCtD
Betamethasone—Malaise—Methotrexate—muscle cancer	6.93e-05	0.00117	CcSEcCtD
Betamethasone—Dizziness—Etoposide—muscle cancer	6.93e-05	0.00117	CcSEcCtD
Betamethasone—Vertigo—Methotrexate—muscle cancer	6.91e-05	0.00117	CcSEcCtD
Betamethasone—Arrhythmia—Doxorubicin—muscle cancer	6.83e-05	0.00116	CcSEcCtD
Betamethasone—Alopecia—Doxorubicin—muscle cancer	6.76e-05	0.00114	CcSEcCtD
Betamethasone—Convulsion—Methotrexate—muscle cancer	6.66e-05	0.00113	CcSEcCtD
Betamethasone—Vomiting—Etoposide—muscle cancer	6.66e-05	0.00113	CcSEcCtD
Betamethasone—Erythema—Doxorubicin—muscle cancer	6.66e-05	0.00113	CcSEcCtD
Betamethasone—Rash—Etoposide—muscle cancer	6.61e-05	0.00112	CcSEcCtD
Betamethasone—Dermatitis—Etoposide—muscle cancer	6.6e-05	0.00112	CcSEcCtD
Betamethasone—Headache—Etoposide—muscle cancer	6.56e-05	0.00111	CcSEcCtD
Betamethasone—Myalgia—Methotrexate—muscle cancer	6.55e-05	0.00111	CcSEcCtD
Betamethasone—Discomfort—Methotrexate—muscle cancer	6.47e-05	0.0011	CcSEcCtD
Betamethasone—Anaphylactic shock—Methotrexate—muscle cancer	6.28e-05	0.00106	CcSEcCtD
Betamethasone—Infection—Methotrexate—muscle cancer	6.23e-05	0.00106	CcSEcCtD
Betamethasone—Nausea—Etoposide—muscle cancer	6.22e-05	0.00105	CcSEcCtD
Betamethasone—Ill-defined disorder—Doxorubicin—muscle cancer	6.18e-05	0.00105	CcSEcCtD
Betamethasone—Nervous system disorder—Methotrexate—muscle cancer	6.15e-05	0.00104	CcSEcCtD
Betamethasone—Thrombocytopenia—Methotrexate—muscle cancer	6.14e-05	0.00104	CcSEcCtD
Betamethasone—Hyperhidrosis—Methotrexate—muscle cancer	6.07e-05	0.00103	CcSEcCtD
Betamethasone—Malaise—Doxorubicin—muscle cancer	6e-05	0.00102	CcSEcCtD
Betamethasone—Vertigo—Doxorubicin—muscle cancer	5.98e-05	0.00101	CcSEcCtD
Betamethasone—Anorexia—Methotrexate—muscle cancer	5.98e-05	0.00101	CcSEcCtD
Betamethasone—Syncope—Doxorubicin—muscle cancer	5.97e-05	0.00101	CcSEcCtD
Betamethasone—Hypotension—Methotrexate—muscle cancer	5.86e-05	0.000993	CcSEcCtD
Betamethasone—Loss of consciousness—Doxorubicin—muscle cancer	5.85e-05	0.000991	CcSEcCtD
Betamethasone—Convulsion—Doxorubicin—muscle cancer	5.77e-05	0.000977	CcSEcCtD
Betamethasone—Hypertension—Doxorubicin—muscle cancer	5.75e-05	0.000974	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Methotrexate—muscle cancer	5.72e-05	0.000968	CcSEcCtD
Betamethasone—Insomnia—Methotrexate—muscle cancer	5.68e-05	0.000961	CcSEcCtD
Betamethasone—Myalgia—Doxorubicin—muscle cancer	5.67e-05	0.00096	CcSEcCtD
Betamethasone—Anxiety—Doxorubicin—muscle cancer	5.65e-05	0.000957	CcSEcCtD
Betamethasone—Paraesthesia—Methotrexate—muscle cancer	5.63e-05	0.000955	CcSEcCtD
Betamethasone—Discomfort—Doxorubicin—muscle cancer	5.6e-05	0.000949	CcSEcCtD
Betamethasone—Dyspepsia—Methotrexate—muscle cancer	5.52e-05	0.000936	CcSEcCtD
Betamethasone—Decreased appetite—Methotrexate—muscle cancer	5.46e-05	0.000924	CcSEcCtD
Betamethasone—Oedema—Doxorubicin—muscle cancer	5.43e-05	0.00092	CcSEcCtD
Betamethasone—Anaphylactic shock—Doxorubicin—muscle cancer	5.43e-05	0.00092	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Methotrexate—muscle cancer	5.42e-05	0.000918	CcSEcCtD
Betamethasone—Fatigue—Methotrexate—muscle cancer	5.41e-05	0.000916	CcSEcCtD
Betamethasone—Infection—Doxorubicin—muscle cancer	5.4e-05	0.000914	CcSEcCtD
Betamethasone—Pain—Methotrexate—muscle cancer	5.37e-05	0.000909	CcSEcCtD
Betamethasone—Shock—Doxorubicin—muscle cancer	5.35e-05	0.000906	CcSEcCtD
Betamethasone—Nervous system disorder—Doxorubicin—muscle cancer	5.33e-05	0.000903	CcSEcCtD
Betamethasone—Thrombocytopenia—Doxorubicin—muscle cancer	5.32e-05	0.000901	CcSEcCtD
Betamethasone—Tachycardia—Doxorubicin—muscle cancer	5.3e-05	0.000898	CcSEcCtD
Betamethasone—Hyperhidrosis—Doxorubicin—muscle cancer	5.25e-05	0.00089	CcSEcCtD
Betamethasone—Anorexia—Doxorubicin—muscle cancer	5.18e-05	0.000877	CcSEcCtD
Betamethasone—Feeling abnormal—Methotrexate—muscle cancer	5.17e-05	0.000876	CcSEcCtD
Betamethasone—Gastrointestinal pain—Methotrexate—muscle cancer	5.13e-05	0.000869	CcSEcCtD
Betamethasone—Hypotension—Doxorubicin—muscle cancer	5.08e-05	0.00086	CcSEcCtD
Betamethasone—Urticaria—Methotrexate—muscle cancer	4.99e-05	0.000844	CcSEcCtD
Betamethasone—Abdominal pain—Methotrexate—muscle cancer	4.96e-05	0.00084	CcSEcCtD
Betamethasone—Body temperature increased—Methotrexate—muscle cancer	4.96e-05	0.00084	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	4.95e-05	0.000839	CcSEcCtD
Betamethasone—Insomnia—Doxorubicin—muscle cancer	4.91e-05	0.000833	CcSEcCtD
Betamethasone—Paraesthesia—Doxorubicin—muscle cancer	4.88e-05	0.000827	CcSEcCtD
Betamethasone—Dyspepsia—Doxorubicin—muscle cancer	4.78e-05	0.00081	CcSEcCtD
Betamethasone—Decreased appetite—Doxorubicin—muscle cancer	4.72e-05	0.0008	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Doxorubicin—muscle cancer	4.69e-05	0.000795	CcSEcCtD
Betamethasone—Fatigue—Doxorubicin—muscle cancer	4.68e-05	0.000794	CcSEcCtD
Betamethasone—Pain—Doxorubicin—muscle cancer	4.65e-05	0.000787	CcSEcCtD
Betamethasone—Asthenia—Methotrexate—muscle cancer	4.5e-05	0.000763	CcSEcCtD
Betamethasone—Feeling abnormal—Doxorubicin—muscle cancer	4.48e-05	0.000759	CcSEcCtD
Betamethasone—Gastrointestinal pain—Doxorubicin—muscle cancer	4.44e-05	0.000753	CcSEcCtD
Betamethasone—Pruritus—Methotrexate—muscle cancer	4.44e-05	0.000752	CcSEcCtD
Betamethasone—Urticaria—Doxorubicin—muscle cancer	4.32e-05	0.000731	CcSEcCtD
Betamethasone—Abdominal pain—Doxorubicin—muscle cancer	4.3e-05	0.000728	CcSEcCtD
Betamethasone—Body temperature increased—Doxorubicin—muscle cancer	4.3e-05	0.000728	CcSEcCtD
Betamethasone—Diarrhoea—Methotrexate—muscle cancer	4.29e-05	0.000727	CcSEcCtD
Betamethasone—Dizziness—Methotrexate—muscle cancer	4.15e-05	0.000703	CcSEcCtD
Betamethasone—Vomiting—Methotrexate—muscle cancer	3.99e-05	0.000676	CcSEcCtD
Betamethasone—Rash—Methotrexate—muscle cancer	3.96e-05	0.00067	CcSEcCtD
Betamethasone—Dermatitis—Methotrexate—muscle cancer	3.95e-05	0.00067	CcSEcCtD
Betamethasone—Headache—Methotrexate—muscle cancer	3.93e-05	0.000666	CcSEcCtD
Betamethasone—Asthenia—Doxorubicin—muscle cancer	3.9e-05	0.00066	CcSEcCtD
Betamethasone—Pruritus—Doxorubicin—muscle cancer	3.84e-05	0.000651	CcSEcCtD
Betamethasone—Nausea—Methotrexate—muscle cancer	3.73e-05	0.000631	CcSEcCtD
Betamethasone—Diarrhoea—Doxorubicin—muscle cancer	3.72e-05	0.00063	CcSEcCtD
Betamethasone—Dizziness—Doxorubicin—muscle cancer	3.59e-05	0.000609	CcSEcCtD
Betamethasone—Vomiting—Doxorubicin—muscle cancer	3.45e-05	0.000585	CcSEcCtD
Betamethasone—Rash—Doxorubicin—muscle cancer	3.43e-05	0.00058	CcSEcCtD
Betamethasone—Dermatitis—Doxorubicin—muscle cancer	3.42e-05	0.00058	CcSEcCtD
Betamethasone—Headache—Doxorubicin—muscle cancer	3.4e-05	0.000577	CcSEcCtD
Betamethasone—Nausea—Doxorubicin—muscle cancer	3.23e-05	0.000547	CcSEcCtD
